Skip to content
DataLookout
Menu

NCT04136717

Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jul 2027 to Jul 2028 Show 5 more changesShow less
    • Eligibility criteria expanded, about 8 words
    • Enrollment closed, study ongoing
    • Study completion pushed from Jun 2028 to Dec 2028
    • Secondary endpoints: details revised at 3 of 4 entries
    • Site details revised
  2. Notable Primary completion date: Jan 2021 to Jul 2027
    • Study completion date: Apr 2021 to Jun 2028
    v4
  3. Notable Primary completion date: Jun 2020 to Jan 2021
    • Study completion date: Dec 2020 to Apr 2021
    v3
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 2019 to Oct 28, 2019
    v2
  5. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Percentage of time within SpO2 target
Timeframe: AECOPD Patients: Day 1; Up to 120 minutes after start study procedures. Bariatric surgery patients: Day 1; up to 75 minutes after start study procedures(post-op).

Secondary (4)

Percentage of time in hypoxemia
Percentage of time in severe hypoxemia
Percentage of time in hyperoxia
PCO2 value after each period

Arms and interventions

COPD patientsOther

Patients with acute exacerbation of COPD and respiratory acidosis under oxygen therapy.

Bariatric surgery patientsOther

Obese patients after gastric surgery under CPAP.

Other: Washout period, CPAP - Oxygen constant flow, CPAP - FreeO2

Devices: NIV - FreeO2, Nasal High flow Oxygen therapy - FreeO2

Sites

1 site in 1 country

  • Institut universitaire de Cardiologie et de Pneumologie - Université LavalQuébec, Quebec, Canada